The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Abstract
Background— Higher levels of serum alkaline phosphatase (AlkP) are associated with excess mortality in dialysis patients, but whether AlkP is associated with adverse outcomes among people without kidney failure is unknown. Methods and Results— We first analyzed the association between AlkP and cardiovascular outcomes among 4115 participants with a previous myocardial infarction (the Cholesterol And Recurrent Events [CARE] study). Results were validated by analyzing the association between AlkP and mortality in an independent sample of 14 716 adults from the general US population (the Third National Health and Nutrition Examination Survey). A graded, independent association was noted between baseline tertile of AlkP and the adjusted hazard ratio of all-cause mortality in CARE participants ( P trend =0.02). After adjustment for serum phosphate, hepatic enzymes, and other potential confounders, participants with AlkP in the highest tertile had an adjusted hazard ratio of 1.43 (95% confidence interval 1.08 to 1.89) compared with those in the lowest tertile. Multivariable-adjusted associations between higher AlkP and all-cause and cardiovascular mortality were present in the Third National Health and Nutrition Examination Survey ( P trend across tertiles of AlkP=0.006 and 0.038, respectively). Findings from both CARE and the Third National Health and Nutrition Examination Survey were similar among individuals with and without evidence of kidney disease, defined by estimated glomerular filtration rate <60 mL · min −1 · 1.73 m −2 . Conclusions— We found an independent relation between higher levels of AlkP and adverse outcomes among survivors of myocardial infarction and in a general population sample. The excess risk of death was present in people without evidence of kidney disease and was particularly high among people with higher levels of both AlkP and serum phosphate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Self-citationHarrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationLong-Term Prognosis Associated With Coronary Calcification
Budoff, M. J., Shaw, L. J., Liu, S. T., Weinstein, S. R., Tseng, P. H., Flores, F. R., Callister, T. Q., Raggi, P., Berman, D. S., & Mosler, T. P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.079 · Cited by 1,342
Bone metabolism and disease in chronic kidney disease
Eknoyan, G., Levin, A., & Levin, N. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00905-3 · Cited by 1,286
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Melamed, M. L., Michos, E. D., Post, W., & Astor, B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1629 · Cited by 1,218
Self-citationVascular Calcification: Pathobiological Mechanisms and Clinical Implications
Johnson, R. C., Leopold, J. A., & Loscalzo, J. (2006) · Circulation Research · doi:10.1161/01.res.0000249379.55535.21 · Cited by 944
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G. (2005) · Circulation · doi:10.1161/circulationaha.105.553198 · Cited by 885
Self-citationDhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Tonelli, M., Sacks, F., Arnold, M., Moye, L., Davis, B., & Pfeffer, M. (2008) · Circulation · doi:10.1161/circulationaha.107.727545 · Cited by 816
Self-citationBlock, G. A., Raggi, P., Bellasi, A., Kooienga, L., & Spiegel, D. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002059 · Cited by 796
Block, G. A., & Port, F. K. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70064-3 · Cited by 594
Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by Akp2, Enpp1, and Ank
Harmey, D., Hessle, L., Narisawa, S., Johnson, K. A., Terkeltaub, R., & Millán, J. L. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63208-7 · Cited by 505
Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
Adeney, K. L., Siscovick, D. S., Ix, J. H., Seliger, S. L., Shlipak, M. G., Jenny, N. S., & Kestenbaum, B. R. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040349 · Cited by 472
Blood Lead Below 0.48 μmol/L (10 μg/dL) and Mortality Among US Adults
Menke, A., Muntner, P., Batuman, V., Silbergeld, E. K., & Guallar, E. (2006) · Circulation · doi:10.1161/circulationaha.106.628321 · Cited by 451
Self-citationSlinin, Y., Foley, R. N., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004040275 · Cited by 423
Lomashvili, K. A., Garg, P., Narisawa, S., Millan, J. L., & O'Neill, W. C. (2008) · Kidney International · doi:10.1038/ki.2008.26 · Cited by 310
Selvin, E., Manzi, J., Stevens, L. A., Van Lente, F., Lacher, D. A., Levey, A. S., & Coresh, J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.08.020 · Cited by 307
Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease: An Overview
Bailie, G. R., & Massry, S. G. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.12.1687 · Cited by 252
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
Palmer, S. C., McGregor, D. O., Macaskill, P., Craig, J. C., Elder, G. J., & Strippoli, G. F. M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-12-200712180-00004 · Cited by 251
Blayney, M. J., Pisoni, R. L., Bragg-Gresham, J. L., Bommer, J., Piera, L., Saito, A., Akiba, T., Keen, M. L., Young, E. W., & Port, F. K. (2008) · Kidney International · doi:10.1038/ki.2008.248 · Cited by 162
Sacks, F. M., Pfeffer, M. A., Moyé, L. A., Brown, L. E., Hamm, P., Cole, T. G., HAWKINS, C. M., Braunwald, E., & The CARE Investigators (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90276-q · Cited by 125
Self-citationClinical and demographic predictors of exercise capacity in end-stage renal disease
Sietsema, K. E., Hiatt, W. R., Esler, A. L., Adler, S. G., Amato, A., & Brass, E. P. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29884 · Cited by 90
Narang, R., Ridout, D. A., Nonis, C., et al. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)02971-9 · Cited by 82
Plan and operation of the NHANES II Mortality Study, 1992.
Loria, C. M., Sempos, C. T., & Vuong, C. (1999) · PubMed · Cited by 42
Coronary Artery Calcification and Total Mortality in Elderly Men
Abbott, R. D., Ueshima, H., Masaki, K., Willcox, B. J., Rodríguez, B. L., Ikeda, A., Yano, K., White, L. R., & Curb, J. D. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01454.x · Cited by 20
Cited by
Durham, A. L., Speer, M. Y., Scatena, M., Giachelli, C. M., & Shanahan, C. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy010 · Cited by 1,093
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Shanahan, C. M., Crouthamel, M. H., Kapustin, A., & Giachelli, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.234914 · Cited by 958
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606087 · Cited by 531
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Metadata
- Authors
- Tonelli, M., Curhan, G., Pfeffer, M., Sacks, F., Thadhani, R., Melamed, M. L., Wiebe, N., & Muntner, P.
- Venue
- Circulation
- Published
- 2009-11-03
- Volume
- 120
- Issue
- 18
- Pages
- 1784-1792
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2136916825
- Cited by
- 280
- References
- 31
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.